1. Liu, Yingzhao, Shi, Lijun, Yuan, Cunzhong, Yao, Desheng, Wang, Qi. 2022. Downregulation of ITIH3 contributes to cisplatin-based chemotherapy resistance in ovarian carcinoma via the Bcl-2 mediated anti-apoptosis signaling pathway. In Oncology letters, 25, 61. doi:10.3892/ol.2022.13646. https://pubmed.ncbi.nlm.nih.gov/36644154/
2. Ebana, Yusuke, Ozaki, Kouichi, Inoue, Katsumi, Nakamura, Yusuke, Tanaka, Toshihiro. 2007. A functional SNP in ITIH3 is associated with susceptibility to myocardial infarction. In Journal of human genetics, 52, 220-229. doi:10.1007/s10038-006-0102-5. https://pubmed.ncbi.nlm.nih.gov/17211523/
3. Shah, Amil M, Myhre, Peder L, Arthur, Victoria, Omland, Torbjørn, Yu, Bing. 2024. Large scale plasma proteomics identifies novel proteins and protein networks associated with heart failure development. In Nature communications, 15, 528. doi:10.1038/s41467-023-44680-3. https://pubmed.ncbi.nlm.nih.gov/38225249/
4. Xie, Xinyan, Meng, Heng, Wu, Hao, Li, Li, Song, Ranran. 2020. Integrative analyses indicate an association between ITIH3 polymorphisms with autism spectrum disorder. In Scientific reports, 10, 5223. doi:10.1038/s41598-020-62189-3. https://pubmed.ncbi.nlm.nih.gov/32251353/
5. Li, Kaiqin, Li, Yifan, Wang, Junyang, Li, Ming, Luo, Xiong-Jian. 2020. A functional missense variant in ITIH3 affects protein expression and neurodevelopment and confers schizophrenia risk in the Han Chinese population. In Journal of genetics and genomics = Yi chuan xue bao, 47, 233-248. doi:10.1016/j.jgg.2020.04.001. https://pubmed.ncbi.nlm.nih.gov/32712163/
智鼠故事 
